Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Clinical trial NCT00002105 · COMPLETED
Trial details
- NCT number
- NCT00002105
- Sponsor
- Sequus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.